4D Molecular Therapeutics, Inc. logo

4D Molecular Therapeutics, Inc.

NASDAQ:FDMT

Overview | Financials
Company Name 4D Molecular Therapeutics, Inc.
Symbol FDMT
Currency USD
Price 8.095
Market Cap 420,693,912
Dividend Yield 0%
52-week-range 7.9 - 36.25
Industry Biotechnology
Sector Healthcare
CEO Dr. David H. Kirn M.D.
Website https://www.4dmoleculartherapeutics.com

An error occurred while fetching data.

About 4D Molecular Therapeutics, Inc.

4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical trials: 4D-125 that is in

Related Stocks

ClearPoint Neuro, Inc. logo

ClearPoint Neuro, Inc.

CLPT

12.89 USD

Ocular Therapeutix, Inc. logo

Ocular Therapeutix, Inc.

OCUL

10.39 USD

Theratechnologies Inc. logo

Theratechnologies Inc.

THTX

1.22 USD

AlloVir, Inc. logo

AlloVir, Inc.

ALVR

0.953 USD

Verastem, Inc. logo

Verastem, Inc.

VSTM

3.92 USD

Financials

Numbers are in millions USD

Numbers are in millions USD